{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:32:21Z","timestamp":1762342341022,"version":"build-2065373602"},"reference-count":37,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Regional Development Fund through the Operational Program \u201cCompetitiveness and Cohesion 2014\u20132020\u201d","award":["KK.01.1.1.04.0115"],"award-info":[{"award-number":["KK.01.1.1.04.0115"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The aim of this cross-sectional study was to evaluate the differences in the levels of advanced glycation end products (AGE) between patients with chronic kidney disease (CKD) and kidney transplant recipients (KTRs) and to investigate the risk factors for the AGE levels in each group of these patients. There were 217 participants total, of which 99 (45.6%) were KTRs and 118 (54.4%) had CKD. Data on the levels of AGE, body mass composition, anthropometric parameters, central and peripheral blood pressure, and clinical and laboratory parameters were gathered for each study participant. The AGE values of the CKD and KTRs groups did not differ from one another. In both groups, a lower estimated glomerular filtration rate, male sex, and older age were positive predictors for increased AGE values. Furthermore, higher levels of AGE were linked to lower central systolic blood pressure (cSBP) in the CKD group, whilst, in the KTRs group, higher levels of AGE were linked to a shorter time since kidney transplantation (KTx), more years of dialysis prior to KTx, lower levels of trunk visceral fat, the presence of arterial hypertension, and the absence of prescriptions for the antihypertensive medications urapidil and angiotensin II receptor blockers. Further studies are needed to better understand the above associations. Consequently, a personalised multidisciplinary approach to assess the cardiovascular as well as dietary and lifestyle risk factors to reduce the AGE levels in both KTRs and CKD patients may be implemented.<\/jats:p>","DOI":"10.3390\/diagnostics14131383","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T03:38:27Z","timestamp":1719805107000},"page":"1383","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2645-7597","authenticated-orcid":false,"given":"Josipa","family":"Radi\u0107","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Dialysis, University Hospital of Split, 21000 Split, Croatia"},{"name":"Department of Internal Medicine, School of Medicine, University of Split, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijana","family":"Vu\u010dkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Dialysis, University Hospital of Split, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2188-0006","authenticated-orcid":false,"given":"Hana","family":"\u0110oga\u0161","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Dialysis, University Hospital of Split, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9195-646X","authenticated-orcid":false,"given":"Andrea","family":"Gelemanovi\u0107","sequence":"additional","affiliation":[{"name":"Mediterranean Institute for Life Sciences (MedILS), 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-6600","authenticated-orcid":false,"given":"Andrej","family":"Belan\u010di\u0107","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Clinical Hospital Centre Rijeka, Kre\u0161imirova 42, 51000 Rijeka, Croatia"},{"name":"Department of Basic and Clinical Pharmacology with Toxicology, Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0350-6800","authenticated-orcid":false,"given":"Mislav","family":"Radi\u0107","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, University of Split, 21000 Split, Croatia"},{"name":"Department of Internal Medicine, Division of Rheumatology, Allergology and Clinical Immunology, University Hospital of Split, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2337\/dc21-2196","article-title":"Advanced glycation end products predict loss of renal function and high-risk chronic kidney disease in type 2 diabetes","volume":"45","author":"Koska","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fotheringham, A.K., Gallo, L.A., Borg, D.J., and Forbes, J.M. (2022). Advanced glycation end products (ages) and chronic kidney disease: Does the modern diet age the kidney?. Nutrients, 14.","DOI":"10.3390\/nu14132675"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1046\/j.1523-1755.2000.00117.x","article-title":"Mechanisms for the formation of glycoxidation products in end-stage renal disease","volume":"57","author":"Weiss","year":"2000","journal-title":"Kidney Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MNH.0b013e32833e9259","article-title":"Skin autofluorescence as a measure of advanced glycation endproduct deposition: A novel risk marker in chronic kidney disease","volume":"19","author":"Smit","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tanaka, K., Nakayama, M., Kanno, M., Kimura, H., Watanabe, K., Tani, Y., Kusano, Y., Suzuki, H., Hayashi, Y., and Asahi, K. (2013). Skin autofluorescence is associated with the progression of chronic kidney disease: A prospective observational study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0083799"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.diabet.2013.03.003","article-title":"Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus","volume":"39","author":"Genevieve","year":"2013","journal-title":"Diabetes Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients","volume":"16","author":"Meerwaldt","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/0886022X.2010.541581","article-title":"Associations of serum levels of advanced glycation end products with nutrition markers and anemia in patients with chronic kidney disease","volume":"33","author":"Zakiyanov","year":"2011","journal-title":"Ren. Fail."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1196\/annals.1333.088","article-title":"Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: Interventional Studies","volume":"1043","author":"Lassila","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.numecd.2010.11.008","article-title":"Circulating soluble receptor for advanced glycation end product (srage) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)","volume":"22","author":"Leonardis","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17647","DOI":"10.1038\/s41598-020-74673-x","article-title":"Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease","volume":"10","author":"Yabuuchi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s004670100038","article-title":"Plasma levels of advanced glycation end products in children with renal disease","volume":"16","author":"Heidland","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1196\/annals.1333.037","article-title":"Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease","volume":"1043","author":"Hartog","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Steenbeke, M., Speeckaert, R., Desmedt, S., Glorieux, G., Delanghe, J.R., and Speeckaert, M.M. (2022). The role of advanced glycation end products and its soluble receptor in kidney diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073439"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2215\/CJN.00540119","article-title":"Circulating advanced glycation endproducts and long-term risk of cardiovascular mortality in kidney transplant recipients","volume":"14","author":"Sotomayor","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.ajkd.2004.02.008","article-title":"Advanced glycation end products in kidney transplant patients: A putative role in the development of chronic renal transplant dysfunction","volume":"43","author":"Hartog","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000355692","article-title":"Tissue advanced glycation end product deposition after kidney transplantation","volume":"124","author":"Crowley","year":"2013","journal-title":"Nephron Clin. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MNH.0000000000000062","article-title":"Advanced glycation end product accumulation","volume":"23","author":"Mallipattu","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_20","unstructured":"(2019, June 23). Diagnoptics. Available online: https:\/\/www.diagnoptics.com\/agereaderapp\/."},{"key":"ref_21","unstructured":"(2019, June 20). Mc780\u2014User Manual. Available online: https:\/\/tanita.eu\/media\/pdf\/products-tanita\/professional\/MC-780\/MC-780MA%20N%20Instruction%20Manual%20%28EN%29%202018%20%282%29.pdf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC Scientific Document Group. 2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_23","unstructured":"(2020). R Core Team R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/www.R-Project.Org\/."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2008.08.031","article-title":"Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis","volume":"53","author":"Meerwaldt","year":"2009","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_25","first-page":"298","article-title":"Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique\u2014Skin Autofluorescence","volume":"6","author":"Oleniuc","year":"2011","journal-title":"Maedica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/cclm-2012-0832","article-title":"Advanced glycation end-products and skin autofluorescence in end-stage renal disease: A review","volume":"52","author":"Arsov","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/HJH.0000000000002879","article-title":"Hypertension in kidney transplantation: A consensus statement of the \u2018hypertension and the kidney\u2019 working group of the European Society of Hypertension","volume":"39","author":"Halimi","year":"2021","journal-title":"J. Hypertens."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Tantisattamo, E., Molnar Miklos, Z., Ho Bing, T., Reddy Uttam, G., Dafoe Donald, C., Ichii, H., Ferrey, A.J., Hanna Ramy, M., Kalantar-Zadeh, K., and Amin, A. (2020). Approach and Management of Hypertension After Kidney Transplantation. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00229"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.21037\/cdt-22-566","article-title":"Addressing kidney health disparities with new national policy: The time is now","volume":"13","author":"Walker","year":"2023","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Vu\u010dkovi\u0107, M., Radi\u0107, J., Gelemanovi\u0107, A., Raos, H., Bu\u010dan Nenadi\u0107, D., Kolak, E., and Radi\u0107, M. (2021). Mediterranean Diet Adherence and Nutritional Status in Dalmatian Kidney Transplant Recipients-Are They Related?. Nutrients, 13.","DOI":"10.3390\/nu13093246"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bu\u010dan Nenadi\u0107, D., Radi\u0107, J., Kolak, E., Vu\u010dkovi\u0107, M., Novak, I., Selak, M., and Radi\u0107, M. (2022). Mediterranean Diet Adherence and Nutritional Status in Dalmatian Diabetic Hypertensive Patients Regarding Presence of Chronic Kidney Disease\u2014Is There Any Difference?. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19042293"},{"key":"ref_33","first-page":"S21","article-title":"Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children\/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation\u2014Are they inter-related?","volume":"56","author":"Heidland","year":"2001","journal-title":"Clin. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1159\/000064095","article-title":"Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol","volume":"92","author":"Padi","year":"2002","journal-title":"Nephron"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1598183","article-title":"Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension?","volume":"26","author":"Prasad","year":"2017","journal-title":"Int. J. Angiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12325-010-0039-0","article-title":"Urapidil, a dual-acting antihypertensive agent: Current usage considerations","volume":"27","author":"Buch","year":"2010","journal-title":"Adv. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/cclm-2012-0850","article-title":"Plasma advanced glycation end products (AGEs) and NF-\u03baB activity are independent determinants of diastolic and pulse pressure","volume":"52","author":"Sourris","year":"2014","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1383\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:07:24Z","timestamp":1760108844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":37,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["diagnostics14131383"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14131383","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}